Inflammasome Therapeutics, Inc., 2026-05-04
An SEC Form D private-offering notice from Newton, MA, a $13,155,645 filer-stated offering target in Biotech. Filed 2026-05-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing oral and implant therapies that target inflammasome activation for retinal and neurodegenerative diseases like geographic atrophy, Alzheimer's, and Parkinson's.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Miach Orthopaedics Inc., 2026-05-07, $6.5M, Westborough, MA
- Locksmith Bio Inc., 2026-05-04, $1.9M, Dover, DE
- Endlyz Therapeutics, Inc., 2026-05-07, $19.7M, Boston, MA
- Mentat Biotechnology, Corp., 2026-05-04, $10K, Daly City, CA
- TN I FF LLC, 2026-05-05, $2.5M, Boston, MA
- PharmassetX Inc., 2026-05-04, $6M, Louisville, KY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.